trial · primary record
TAR-200
Urinary Bladder Neoplasms
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 220 |
| Primary completion | 2027-09-30 |
| Primary endpoint | Cohorts 1, 2, and 3: Overall Complete Response (CR) Rate |
| Registry ID | NCT04640623 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:48.654Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04640623
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Tar-200 · compound